Who Paid My Doc
Rachel Wolkow
Nurse Practitioner Sioux Falls, SD Nurse Practitioner
NPI 1245864693 CMS profile 10863325
1301 S Cliff Ave, Sioux Falls, SD 57105
General payments
$1,509
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Rachel Wolkow of Sioux Falls, SD is reported in the CMS Open Payments database as having received $1,509 across 30 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 76th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $748 | 11 | |
| 2024 | General | $199 | 5 | |
| 2023 | General | $355 | 6 | |
| 2022 | General | $206 | 8 |
Beside peers
- Rachel Wolkow
- Nurse Practitioner median
- Middle half of Nurse Practitioner
- National median
In program year 2025, general payments to Rachel Wolkow were reported at $748. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.
Show as a table
| Year | Rachel Wolkow | Nurse Practitioner median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $50 | $22–$97 | $163 |
| 2020 | $0 | $40 | $16–$108 | $114 |
| 2021 | $0 | $135 | $40–$426 | $132 |
| 2022 | $206 | $152 | $48–$470 | $149 |
| 2023 | $355 | $166 | $54–$529 | $160 |
| 2024 | $199 | $173 | $55–$556 | $164 |
| 2025 | $748 | $174 | $55–$557 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 28 billing codesPaid by Medicare
$23,116
Medicare patients
147
Services billed
618
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 49% | |
| Diabetes | 48% | |
| Chronic kidney disease | 43% | |
| Ischemic heart disease | 39% | |
| Depression | 36% | |
| Heart failure | 34% | |
| Atrial fibrillation | 33% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
30 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner in South Dakota
Jamie Busch
Nurse Practitioner · Sioux Falls, SD
Jessica Slaba
Nurse Practitioner · Sioux Falls, SD
Christopher Nelson
Nurse Practitioner · Sioux Falls, SD
Katherine Ericson
Nurse Practitioner · Sioux Falls, SD
Rosa Eyton
Nurse Practitioner · Aberdeen, SD
Kristi Glanzer
Nurse Practitioner · Huron, SD
Related records
Nurse Practitioner in South Dakota
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner
Everyone recorded under this specialty, nationwide.
Doctors in South Dakota
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.